JP2010505869A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505869A5 JP2010505869A5 JP2009531568A JP2009531568A JP2010505869A5 JP 2010505869 A5 JP2010505869 A5 JP 2010505869A5 JP 2009531568 A JP2009531568 A JP 2009531568A JP 2009531568 A JP2009531568 A JP 2009531568A JP 2010505869 A5 JP2010505869 A5 JP 2010505869A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- group
- disease
- treating
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 32
- 150000001875 compounds Chemical class 0.000 claims 16
- 208000036142 Viral infection Diseases 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 208000027866 inflammatory disease Diseases 0.000 claims 8
- 208000030159 metabolic disease Diseases 0.000 claims 8
- 230000002062 proliferating effect Effects 0.000 claims 8
- 208000019553 vascular disease Diseases 0.000 claims 8
- 230000009385 viral infection Effects 0.000 claims 8
- 125000005842 heteroatom Chemical group 0.000 claims 5
- -1 butane bridge-modified nordihydroguaiaretic acid derivative compound Chemical class 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 239000000460 chlorine Substances 0.000 claims 3
- 208000016097 disease of metabolism Diseases 0.000 claims 3
- 150000002430 hydrocarbons Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001960 7 membered carbocyclic group Chemical group 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 229910052783 alkali metal Inorganic materials 0.000 claims 2
- 239000001273 butane Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82778306P | 2006-10-02 | 2006-10-02 | |
| US60/827,783 | 2006-10-02 | ||
| PCT/US2007/080231 WO2008042921A2 (en) | 2006-10-02 | 2007-10-02 | Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010505869A JP2010505869A (ja) | 2010-02-25 |
| JP2010505869A5 true JP2010505869A5 (enExample) | 2011-11-17 |
| JP5362572B2 JP5362572B2 (ja) | 2013-12-11 |
Family
ID=39269174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531568A Expired - Fee Related JP5362572B2 (ja) | 2006-10-02 | 2007-10-02 | テトラ−ｏ−置換ブタン架橋修飾ｎｄｇａ誘導体、それらの合成および薬学的使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US8232277B2 (enExample) |
| EP (1) | EP2076125B1 (enExample) |
| JP (1) | JP5362572B2 (enExample) |
| CN (1) | CN101547602B (enExample) |
| ES (1) | ES2449237T3 (enExample) |
| WO (1) | WO2008042921A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010011117A2 (ko) * | 2008-07-25 | 2010-01-28 | 국립암센터 | Ｎｄｇａ를 포함하는 트란스글루타미나제 억제용 조성물 |
| US20100093872A1 (en) * | 2008-10-15 | 2010-04-15 | Erimos Pharmaceuticals Llc | Stable aqueous formulations of water insoluble or poorly soluble drugs |
| WO2012145749A1 (en) | 2011-04-22 | 2012-10-26 | Napo Pharmaceuticals, Inc. | Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga) |
| US9084779B2 (en) * | 2011-05-31 | 2015-07-21 | The Johns Hopkins University | Conjugates of nitroimidazoles and their use as chemotherapeutic agents |
| EP2961412A4 (en) * | 2013-02-26 | 2016-11-09 | Triact Therapeutics Inc | CANCER THERAPY |
| US9993460B2 (en) | 2013-07-26 | 2018-06-12 | Race Oncology Ltd. | Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof |
| JP7504304B2 (ja) | 2021-01-19 | 2024-06-21 | エリモス・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー | コロナウイルス抗ウイルス剤としてのテラメプロコールおよびノルジヒドログアイアレチン酸（ｎｄｇａ）誘導体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708964A (en) * | 1984-02-09 | 1987-11-24 | Chemex Pharmaceuticals | Lipoxygenase inhibitors |
| WO1988003805A1 (en) * | 1986-11-19 | 1988-06-02 | Chemex Pharmaceuticals, Inc. | Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts |
| KR890700023A (ko) * | 1986-11-19 | 1989-03-02 | 케맥스 파마슈우티칼스 인코포레이티드 | 리폭시게나제 저해제 |
| US6579880B2 (en) * | 2000-06-06 | 2003-06-17 | Ortho-Mcneil Pharmaceutical, Inc. | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 |
| JP2005533042A (ja) * | 2002-06-10 | 2005-11-04 | オクラホマ メディカル リサーチ ファウンデーション | 中枢神経系の炎症状態の治療において連結ビス（ポリヒドロキシフェニル）およびそのｏ−アルキル誘導体を使用するための方法 |
| JP5069130B2 (ja) * | 2005-01-27 | 2012-11-07 | エリモス・ファーマスーティカルズ・エルエルシー | Ｎｄｇａ化合物を包含するカテコールブタンの送達のための経口用製剤 |
| US7741357B1 (en) * | 2006-04-17 | 2010-06-22 | Johns Hopkins University | Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents |
-
2007
- 2007-10-02 ES ES07853744.6T patent/ES2449237T3/es active Active
- 2007-10-02 US US12/443,926 patent/US8232277B2/en active Active - Reinstated
- 2007-10-02 EP EP07853744.6A patent/EP2076125B1/en not_active Not-in-force
- 2007-10-02 WO PCT/US2007/080231 patent/WO2008042921A2/en not_active Ceased
- 2007-10-02 CN CN200780044510.7A patent/CN101547602B/zh active Active
- 2007-10-02 JP JP2009531568A patent/JP5362572B2/ja not_active Expired - Fee Related
-
2012
- 2012-07-30 US US13/561,517 patent/US8691845B2/en active Active - Reinstated
-
2014
- 2014-04-07 US US14/246,741 patent/US9481660B2/en active Active - Reinstated
-
2016
- 2016-10-31 US US15/339,822 patent/US20170044121A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505865A5 (enExample) | ||
| JP2010505869A5 (enExample) | ||
| JP2012525393A5 (enExample) | ||
| JP2021063088A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2008543854A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| JP2013508279A5 (enExample) | ||
| JP2004516314A5 (enExample) | ||
| JP2017537940A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2016512202A5 (enExample) | ||
| JP2006506425A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2009502743A5 (enExample) | ||
| JP2015537020A5 (enExample) | ||
| JP2016510769A5 (enExample) | ||
| JP2013522229A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2014530838A5 (enExample) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| RU2011124894A (ru) | Триазолотиадиазоловый ингибитор протеинкиназы с-мет | |
| JP2016528273A5 (enExample) | ||
| RU2013155509A (ru) | Применение ингибирования катепсина к для лечения и/или профилактики легочной гипертензии и/или сердечной недостаточности | |
| JP2012508256A5 (enExample) |